Evidence map›Paper›PMID 26194156›Full record

ReviewCurrent diabetes reports2015

From Individuals to International Policy: Achievements and Ongoing Needs in Diabetes Advocacy.

Marisa E Hilliard, Sean M Oser, Kelly L Close, Nancy F Liu, Korey K Hood, Barbara J Anderson

Abstract readReview
In one paragraph

Review in Current diabetes reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. How might diabetes organisations address diabetes-related stigma? Findings from a deliberative democratic case study.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marisa E HilliardBaylor College of Medicine, 1102 Bates Avenue, Suite 940, Houston, TX, 77030, USA, marisa.hilliard@bcm.edu.
Sean M Oser
Kelly L Close
Nancy F Liu
Korey K Hood
Barbara J Anderson

Funding

Optimizing Self-Management Adherence and Glycemic Control in Older Teens with T1DR01DK095273 · NIDDK · JOSLIN DIABETES CENTER · PI ANDERSON, BARBARA JANE, LAFFEL, LORI M · 2012 to 2015
$2.7M
Using a Closed-Loop System Plus Behavioral Supports in Preschoolers with DiabetesDP3DK104059 · NIDDK · STANFORD UNIVERSITY · PI BUCKINGHAM, BRUCE A, DIMEGLIO, LINDA A · 2014 to 2014
$2.1M
Mentoring Behavioral Scientists for Career Development in Pediatric T1D ResearchK12DK097696 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI ANDERSON, BARBARA JANE · 2012 to 2016
$1.8M
Analyzing Patient Blog Use and Provider Perceptions to Identify Barriers and Facilitators to Type 1 Diabetes Self-Management: An Exploratory Mixed-Methods StudyDP3DK104054 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI OSER, SEAN M, STUCKEY, HEATHER L. · 2014 to 2014
$481k
NIDDK NIH HHS DP3 DK 104054NIDDK NIH HHS DP3 DK104054NIDDK NIH HHS DP3 DK 104059NIDDK NIH HHS DP3 DK104059NIDDK NIH HHS K12 DK097696NIDDK NIH HHS R01 DK 095273NIDDK NIH HHS R01 DK095273NIDDK NIH HHS R01 DK 901470,
6 · The paper itself

Abstract

Diabetes impacts tens of millions of people in the United States of America and 9 % of the worldwide population. Given the public health implications and economic burden of diabetes, the needs of people with diabetes must be addressed through strategic and effective advocacy efforts. Diabetes advocacy aims to increase public awareness about diabetes, raise funds for research and care, influence policy impacting people with diabetes, and promote optimal individual outcomes. We present a framework for diabetes advocacy activities by individuals and at the community, national, and international levels and identify challenges and gaps in current diabetes advocacy. Various groups have organized successful diabetes advocacy campaigns toward these goals, and lessons for further advancing diabetes advocacy can be learned from other health-related populations. Finally, we discuss the role of healthcare providers and mental/behavioral health professionals in advocacy efforts that can benefit their patients and the broader population of people with diabetes.

Indexed as

Diabetes MellitusHumansPublic PolicyUnited StatesUnited States Food and Drug Administration

Identifiers

PMID26194156
PMCPMC4581582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.